A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis
Cibeira, Maria T., Oriol, Albert, Lahuerta, Juan J., Mateos, Maria-Victoria, de la Rubia, Javier, Hernández, Miguel T., Granell, Miquel, Fernández de Larrea, Carlos, San Miguel, Jesús F., Bladé, JoanVolume:
170
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13500
Date:
September, 2015
File:
PDF, 189 KB
english, 2015